Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
99615-7 Current anti-inflammatory drug use Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Current anti-inflammatory drug use &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; H&P.HX &nbsp; 99615-7 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Current anti-inflammatory drug use &nbsp; &nbsp; &nbsp; N &nbsp; AOEObservation; Drugs; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99616-5 Trienoate/Arachidonate SRto RBC.lysate Pt Qn &nbsp; &nbsp; ACTIVE Trienoate (C20:3w9)/Arachidonate (C20:4w6) [Molar ratio] in RBC.lysate &nbsp; ADD DefinitionDescription &nbsp; &nbsp; {ratio} &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99616-5 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Trienoate/AA RBC.lysate-sRto &nbsp; &nbsp; &nbsp; N &nbsp; 5,8,11,14 Eicosatetraenoic acid; 5,8,11-eicosatrienoic acid 20:3 w9; AA; Arachidonic acid; Arch acid; C20:4w6; Chemistry; Eicosatetraenoate; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Scrto; Substance concentration ratio; Substance ratio; Trienoic acid 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {ratio} &nbsp; &nbsp; &nbsp; 0
99617-3 Fatty acids.saturated SCnc RBC.lysate Pt Qn &nbsp; &nbsp; ACTIVE Saturated fatty acids [Moles/volume] in RBC.lysate &nbsp; ADD DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99617-3 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Sat FA RBC.lysate-sCnc &nbsp; &nbsp; &nbsp; N &nbsp; Acd; Acid; Chemistry; Erythrocytes; Fatty acid; Level; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Sat FA; Substance Concentration 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
99618-1 Fatty acids.monounsaturated SCnc RBC.lysate Pt Qn &nbsp; &nbsp; ACTIVE Monounsaturated fatty acids [Moles/volume] in RBC.lysate &nbsp; ADD DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99618-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Monounsat FA RBC.lysate-sCnc &nbsp; &nbsp; &nbsp; N &nbsp; Acd; Acid; Chemistry; Erythrocytes; Fatty acid; Level; Lipid; Monounsat FA; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
99619-9 Fatty acids.polyunsaturated SCnc RBC.lysate Pt Qn &nbsp; &nbsp; ACTIVE Polyunsaturated fatty acids [Moles/volume] in RBC.lysate &nbsp; ADD DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99619-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Polyunsat FA RBC.lysate-sCnc &nbsp; &nbsp; &nbsp; N &nbsp; Acd; Acid; Chemistry; Erythrocytes; Fatty acid; Level; Lipid; Point in time; Polyunsat FA; PUFA; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
9962-2 QRS initial amplitude.lead AVL Elpot Heart Pt Qn EKG &nbsp; ACTIVE QRS initial amplitude in lead AVL &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 9962-2 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 QRS I-Amp L-AVL &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; QRS I-Amp L-AVL; Quan; Quant; Quantitative; Random; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
99620-7 Fatty acids.omega 3 SCnc RBC.lysate Pt Qn &nbsp; &nbsp; ACTIVE Omega 3 fatty acids (w3) [Moles/volume] in RBC.lysate &nbsp; ADD DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99620-7 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 w3 FA RBC.lysate-sCnc &nbsp; &nbsp; &nbsp; N &nbsp; Acd; Acid; Chemistry; Erythrocytes; Fatty acid; III; Level; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration; w3 FA 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
99621-5 Fatty acids.omega 6 SCnc RBC.lysate Pt Qn &nbsp; &nbsp; ACTIVE Omega 6 fatty acids (w6) [Moles/volume] in RBC.lysate &nbsp; ADD DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 99621-5 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 w6 FA RBC.lysate-sCnc &nbsp; &nbsp; &nbsp; N &nbsp; Acd; Acid; Chemistry; Erythrocytes; Fatty acid; Level; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration; w6 FA 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
99622-3 Resource information for patient Find ^Patient Pt Doc &nbsp; &nbsp; ACTIVE Resource information for patient &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DOC.MISC &nbsp; 99622-3 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Patient resource info &nbsp; &nbsp; &nbsp; N &nbsp; DOC.MISC; Document; Finding; Findings; MISC; Patient resource info; Point in time; Random 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99623-1 Influenza virus A N1 RNA PrThr XXX Pt Ord Probe.amp.tar &nbsp; ACTIVE Influenza virus A N1 RNA [Presence] in Specimen by NAA with probe detection &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 99623-1 &nbsp; Probe.amp.tar &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 FLUAV N1 RNA Spec Ql NAA+probe &nbsp; &nbsp; &nbsp; N &nbsp; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV N1; FLUV; Fowl plague; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99624-9 Japanese encephalitis virus Ab.IgG PrThr Ser Pt Ord IA &nbsp; ACTIVE Japanese encephalitis virus IgG Ab [Presence] in Serum by Immunoassay &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 99624-9 &nbsp; IA &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 JEV IgG Ser Ql IA &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; Flavivirus; IAA; Immune globulin G; Immunoglobulin G; Japanese B encephalitis; Japanese encephalitis; JBE; JE virus; JEV; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99625-6 Purkinje cell cytoplasmic type 2 Ab PrThr Ser Pt Ord Line blot &nbsp; ACTIVE PCA-2 Ab [Presence] in Serum by Line blot &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 99625-6 &nbsp; Line blot &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 PCA-2 Ab Ser Ql Line blot &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cytopl; Cytoplas; II; Ordinal; Paraneoplastic syndrome; PCA-2; PCA-2 Ab; PCCA-2; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99626-4 Purkinje cell cytoplasmic type 2 Ab PrThr CSF Pt Ord Line blot &nbsp; ACTIVE PCA-2 Ab [Presence] in Cerebral spinal fluid by Line blot &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SERO &nbsp; 99626-4 &nbsp; Line blot &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 PCA-2 Ab CSF Ql Line blot &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; II; Ordinal; Paraneoplastic syndrome; PCA-2; PCA-2 Ab; PCCA-2; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99627-2 How often does this describe you, I don't have enough money to pay my bills Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE How often does this describe you, I don't have enough money to pay my bills &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.SDOH &nbsp; 99627-2 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; T prime 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99628-0 Multisection Find Neck+Chest+Abdomen+Pelvis Pt Doc CT &nbsp; ACTIVE CT Neck+Chest+Abdomen+Pelvis &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; RAD &nbsp; 99628-0 &nbsp; CT &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 CT Neck to Pelvis &nbsp; &nbsp; &nbsp; N &nbsp; Abd; Abd+Pelvis; Abdo; Abdominal; CAT scan; Chest + Abd; Chest+Abd+Pelvis; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; Neck to Pelvis; Pelvic; Point in time; Radiology; Random; Thorax 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99629-8 Multisection^WO contrast Find Neck+Chest+Abdomen+Pelvis Pt Doc CT &nbsp; ACTIVE CT Neck+Chest+Abdomen+Pelvis WO contrast &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; RAD &nbsp; 99629-8 &nbsp; CT &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 CT Neck to Pelvis WO contr &nbsp; &nbsp; &nbsp; N &nbsp; Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Chest + Abd; Chest+Abd+Pelvis; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Neck to Pelvis; Pelvic; Point in time; Radiology; Random; Thorax; without contrast 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
9963-0 QRS initial amplitude.lead AVR Elpot Heart Pt Qn EKG &nbsp; ACTIVE QRS initial amplitude in lead AVR &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 9963-0 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 QRS I-Amp L-AVR &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; QRS I-Amp L-AVR; Quan; Quant; Quantitative; Random; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
99630-6 Multisection^WO & W contrast IV Find Neck+Chest+Abdomen+Pelvis Pt Doc CT &nbsp; ACTIVE CT Neck+Chest+Abdomen+Pelvis WO and W contrast IV &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; RAD &nbsp; 99630-6 &nbsp; CT &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 CT Neck to Pelvis WO+W contr IV &nbsp; &nbsp; &nbsp; N &nbsp; Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Chest + Abd; Chest+Abd+Pelvis; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Neck to Pelvis; Pelvic; Point in time; Radiology; Random; Thorax; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99631-4 Multisection Find Head>Temporomandibular joint.bilateral Pt Doc CT.cone beam &nbsp; ACTIVE Cone beam CT Temporomandibular joint - bilateral &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; RAD &nbsp; 99631-4 &nbsp; CT.cone beam &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 CBCT TMJ-Bl &nbsp; &nbsp; &nbsp; N &nbsp; Bil; Bilat; Both; Brain; CAT scan; CBCT; Computed tomography; Computerized tomography; Cone beam CT; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; Jnt; Point in time; Radiology; Random; Skull; TMJ; TMJ-Bl; TMJS 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99632-2 Multisection^WO & W contrast IV Find Head>Temporomandibular joint Pt Doc CT.cone beam &nbsp; ACTIVE Cone beam CT Temporomandibular joint WO and W contrast IV &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; RAD &nbsp; 99632-2 &nbsp; CT.cone beam &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 CBCT TMJ WO+W contr IV &nbsp; &nbsp; &nbsp; N &nbsp; Brain; c; CAT scan; CBCT; Computed tomography; Computerized tomography; Cone beam CT; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; Jnt; Point in time; Radiology; Random; Skull; TMJ; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99633-0 Multisection Find Head>Teeth Pt Doc CT.cone beam &nbsp; ACTIVE Cone beam CT Teeth &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; RAD &nbsp; 99633-0 &nbsp; CT.cone beam &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 CBCT Teeth &nbsp; &nbsp; &nbsp; N &nbsp; Brain; CAT scan; CBCT; Computed tomography; Computerized tomography; Cone beam CT; Cranial; Cranium; CT scan; Dental scan; Dentascan; Document; Finding; Findings; Imaging; Intracranial; Point in time; Radiology; Random; Skull 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99634-8 Federal, state, or local governments required limiting non-essential travel Find ^Patient Pt Ord &nbsp; &nbsp; ACTIVE Federal, state, or local governments required limiting non-essential travel &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.COVID &nbsp; 99634-8 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99635-5 Main symptoms experienced by people infected with condition of interest Find ^Patient Pt Nom &nbsp; &nbsp; ACTIVE Main symptoms experienced by people infected with condition of interest &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.GNHLTH &nbsp; 99635-5 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Disease; Disorder; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH; Sx; Virus 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99636-3 Activity related to possible exposure to condition of interest Find ^Patient 7D Nom &nbsp; &nbsp; ACTIVE Activity related to possible exposure to condition of interest &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.GNHLTH &nbsp; 99636-3 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Activ; Actvty; Disease; Disorder; Exp; Finding; Findings; Movements; Nominal; Survey; SURVEY.GNHLTH; Virus 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
99637-1 Measures taken to keep safe from condition of interest Find ^Patient RptPeriod Nom &nbsp; &nbsp; ACTIVE Measures taken to keep safe from condition of interest &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.GNHLTH &nbsp; 99637-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Disease; Disorder; Finding; Findings; Nominal; Report period; Survey; SURVEY.GNHLTH; Virus 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
108,248 results found